Brief: Aurinia Pharmaceuticals To Release Second Quarter 2025 Financial And Operational Results On July 31, 2025
22/07/2025 11:08
July 22 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O: AURINIA PHARMACEUTICALS TO RELEASE SECOND QUARTER 2025 FINANCIAL AND OPERATIONAL RESULTS ON JULY 31, 2025 Source text: ID:nBw5bJNBja Further company coverage: AUPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death